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compromised hosts. There is a growing number of reports
on the incidence of invasive pulmonary aspergillosis (IPA) in
patients without typical risk factors, such as use of corti-
costeroids and critical illness.1 Here, we report a case of
IPA involving severe complicated influenza A.
A 63-year-old woman with diabetes mellitus presented
with fever, myalgias, and nonproductive cough. She was
normotensive and tachypneic. Her oxygen saturation by
pulse oximeter was 88% on room air. Bilaterally diffuse rales
breath sounds were auscultated. Laboratory tests showed
leukocytosis (a leukocyte count of 12,700 cells/mm3) with
polymorphonuclear predominance, and an abrupt rise of
serum creatinine level up to 2.2 mg/dL. Her chest X-ray
showed bilateral alveolar infiltration (Fig. 1A). The patient
was admitted to the intensive care unit under the impres-
sion of pneumonia and acute kidney injury. She received
levofloxacin, imipenem/cilastatin, teicoplanin, oseltamivir,
and methylprednisolone. The rapid diagnostic test for
influenza A and B showed a negative result. She then
experienced respiratory distress and was intubated on Day
2. The chest X-ray showed worsening bilateral infiltrates
(Fig. 1B), and the PaO2/FiO2 ratio was 61. The results of
repeated rapid test for influenza A and B were negative. A
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was confirmed as H3 species by the Centers for Disease
Control, Taiwan, R.O.C. Because the sputum culture
revealed a growth of hyphae, we performed the aspergillus
galactomannan antigen (AGA) test on Day 9. The AGA
tested positive in serum (5.74 index) and endotracheal
aspirate (7.14 index). Intravenous voriconazole was initi-
ated, but the patient’s condition deteriorated. She later
developed septic shock, oligoanuria, and pneumothorax
(Fig. 1C), and died on Day 11.
The serum and bronchoalveolar lavage AGA test is pri-
marily used for the detection of IPA. Our patient had pos-
itive AGA test results in serum and endotracheal aspirate.
Although endotracheal aspirate is not a standard specimen,
we used it as an alternative for bronchoalveolar lavage.
Because of severe acute respiratory distress syndrome,
bronchoscopy was infeasible.
There are several case reports of IPA complicated by
influenza A. Wauters et al2 reported 40 critically ill adult
patients with confirmed influenza A (H1N1) virus infection.
IPA was diagnosed in 23% of these patients. Use of corti-
costeroid 7 days prior to intensive care unit admission was
an independent risk factor. The overall mortality was 35%.2
Wu et al3 reported 206 laboratory-confirmed adult patients
with influenza and found that the presence of coronary
artery disease, systemic corticosteroid use, impaired renal
function, and delayed hospital visit were independent risk
factors for the development of complications. Despite some
controversy, corticosteroids are often administered to pa-
tients with acute respiratory distress syndrome.4 Although
our patient had no typical risk factors of aspergillosis, the& Formosan Medical Association. All rights reserved.
Figure 1 (A) Plain chest film on admission shows bilateral diffuse alveolar infiltration. (B) Plain chest film on Day 2 shows
worsening bilateral infiltrates, compatible with acute respiratory distress syndrome (ARDS). (C) The final plain chest film shows
pneumothorax and subcutaneous emphysema with bilateral pigtail tube placement.
Invasive pulmonary aspergillosis in influenza A 811critical illness and use of corticosteroid may have predis-
posed her to the disease. Influenza viruses have been re-
ported to cause defects in cellular immunity, leukocyte
dysfunction, and disruption of normal ciliary clearance.5
These abnormalities, along with the additive effect of the
use of corticosteroids, may form the risk factors for IPA in
immunocompetent patients with influenza A disease.
Prompt diagnostic studies should be considered to ensure
early diagnosis and treatment in patients with worsening
respiratory symptoms.References
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